Identification of potential COVID-19 main protease inhibitors using structure-based pharmacophore approach, molecular docking and repurposing studies
By: Safa Daoud, Shada J. Alabed and Lina A. Dahabiyeh
Authors
Safa Daoud
Department of Pharmaceutical, Chemistry and Pharmacognosy, Faculty of Pharmacy, Applied Science, Private University, Amman, Jordan
Shada J. Alabed
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
Lina A. Dahabiyeh
Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman, Jordan
Language: English
Page range: 163 - 174
Accepted on: Jun 2, 2020
Published on: Nov 4, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 Safa Daoud, Shada J. Alabed, Lina A. Dahabiyeh, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.